Literature DB >> 24614069

Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.

Jennifer Walsh1, Anne Cram2, Katharina Woertz3, Joerg Breitkreutz4, Gesine Winzenburg5, Roy Turner6, Catherine Tuleu7.   

Abstract

The development of paediatric medicines can be challenging since this is a diverse patient population with specific needs. For example, the toxicity of excipients may differ in children compared to adults and children have different taste preferences. Acceptable palatability of oral paediatric medicinal products is of great importance to facilitate patient adherence. This has been recognised by regulatory authorities and so is becoming a key aspect of paediatric pharmaceutical development studies. Many active pharmaceutical ingredients (APIs) have aversive taste characteristics and so it is necessary to utilise taste masking techniques to improve the palatability of paediatric oral formulations. The aim of this review is to provide an overview of different approaches to taste masking APIs in paediatric oral dosage forms, with a focus on the tolerability of excipients used. In addition, where possible, the provision of examples of some marketed products is made.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dosage form; Excipient; Formulation; Paediatric; Palatability; Taste masking

Mesh:

Substances:

Year:  2014        PMID: 24614069     DOI: 10.1016/j.addr.2014.02.012

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  40 in total

1.  Using the Slug Mucosal Irritation Assay to Investigate the Tolerability of Tablet Excipients on Human Skin in the Context of the Use of a Nipple Shield Delivery System.

Authors:  Richard Kendall; Joke Lenoir; Stephen Gerrard; Rebekah L Scheuerle; Nigel K H Slater; Catherine Tuleu
Journal:  Pharm Res       Date:  2017-02-13       Impact factor: 4.200

Review 2.  Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.

Authors:  Maren Preis
Journal:  AAPS PharmSciTech       Date:  2015-03-05       Impact factor: 3.246

3.  Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients.

Authors:  Gueorgui Dubrocq; Natella Rakhmanina; B Ryan Phelps
Journal:  Paediatr Drugs       Date:  2017-04       Impact factor: 3.022

Review 4.  Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.

Authors:  William Wei Lim Chin; Angelika Joos
Journal:  Eur J Pediatr       Date:  2016-09-19       Impact factor: 3.183

5.  3D Printed "Starmix" Drug Loaded Dosage Forms for Paediatric Applications.

Authors:  Nicolaos Scoutaris; Steven A Ross; Dennis Douroumis
Journal:  Pharm Res       Date:  2018-01-16       Impact factor: 4.200

6.  Development and Evaluation of Cocoa Butter Taste Masked Ibuprofen Using Supercritical Carbon Dioxide.

Authors:  Rana Obaidat; Haneen Aleih; Hadeia Mashaqbeh; Bashar Altaani; Mo'tasem M Alsmadi; Mohammad Alnaief
Journal:  AAPS PharmSciTech       Date:  2021-03-14       Impact factor: 3.246

7.  Personal Variation in Preference for Sweetness: Effects of Age and Obesity.

Authors:  Nuala Bobowski; Julie A Mennella
Journal:  Child Obes       Date:  2017-05-12       Impact factor: 2.992

8.  A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).

Authors:  Catherine Guittet; Maria Manso; Ingrid Burton; Luc-André Granier; Frédéric Marçon
Journal:  Pharm Res       Date:  2017-06-02       Impact factor: 4.200

9.  Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technology.

Authors:  Sultan M Alshehri; Jun-Bom Park; Bader B Alsulays; Roshan V Tiwari; Bjad Almutairy; Abdullah S Alshetaili; Joseph Morott; Sejal Shah; Vijay Kulkarni; Soumyajit Majumdar; Scott T Martin; Sanjay Mishra; Lijia Wang; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2015-06-01       Impact factor: 3.981

10.  Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary Results.

Authors:  Leslie A Favier; Janalee Taylor; Kristin Loiselle Rich; Karla B Jones; Sheetal S Vora; Julia G Harris; Beth S Gottlieb; Lisa Robbins; Jamie T Lai; Tzielan Lee; Melanie Kohlheim; Jennifer Gill; Laura Bouslaugh; Angela Young; Nancy Griffin; Esi M Morgan; Avani C Modi
Journal:  J Rheumatol       Date:  2018-02-01       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.